ABBV

AbbVie Inc.

  • sector: Healthcare
  • exchange: NYSE
  • in 4 Arithmos indices

Indices that include ABBV 4/4

sort
weight≥ 0.0%
alongside
  1. #1

    Defensive US Core 20

    ABBV · 7.14%LLYWMTUNHCOST+9 more

    AbbVie Inc. — 3.4% dividend yield; Healthcare.

    CAGR
    14.1%
    Sharpe
    0.84
    max DD
    -25.9%
  2. #2

    Recession-Resilient US Defensive 20 — Equal-Weighted

    ABBV · 5.00%JNJUNHMRKABT+15 more

    Leading biopharmaceutical company with blockbuster immunology franchise (Humira, Skyrizi, Rinvoq); 72% gross margin and strong ROE indicate robust cash generation. Equal-weighted per user specification.

    CAGR
    8.6%
    Sharpe
    0.57
    max DD
    -26.3%
  3. #3

    Recession-Resilient US Defensive 20 — Equal-Weighted

    ABBV · 5.00%PGKOPEPCL+15 more

    Biopharmaceutical leader with $363B market cap, 72% gross margin, and 10% revenue growth. Equal-weighted at 5%; strong drug portfolio including Humira franchise generates substantial free cash flow.

    CAGR
    2.5%
    Sharpe
    0.20
    max DD
    -14.2%
  4. #4

    Longevity & Healthspan Index

    ABBV · 8.00%UNITYEXASILMNVCNX+7 more

    Skyrizi/Rinvoq immunology franchise plus aesthetics; longevity wellness overlap.

    CAGR
    –
    Sharpe
    –
    max DD
    –

Build your own index that includes ABBV.

Write a plain-English prompt, get transparent rules and a 10-year backtest.

start a prompt →

Performance figures are simulated backtests, not live returns. Past performance does not predict future results. Arithmos is a research and data tool, not investment advice.

/home·/markets·/feed·/leaderboard·/sharpe·/blog·/pricing·/about·/vacancies·/contact·/links·/terms
⚠Investment research & data tool · not investment advice · not a regulated broker or advisor · past performance does not guarantee future results.